Settlement for $7 billion approved over Roundup cancer claims
A $7 billion settlement was issued on Friday over agrochemical giant Bayer’s popular weedkiller Roundup, which plaintiffs claimed caused non-Hodgkin lymphoma.

TL;DR
- Bayer agreed to a $7 billion settlement regarding Roundup cancer claims.
- The settlement addresses lawsuits alleging Roundup caused non-Hodgkin lymphoma.
- Payments will be made to thousands of Americans over a 20-year period.
- Bayer denies any wrongdoing and has modified Roundup for residential use.
- The settlement comes after a Supreme Court ruling on state court lawsuits for cancer warnings.
- Non-Hodgkin lymphoma is a cancer of the lymphatic system.
- The EPA states Roundup's active ingredient, glyphosate, is not cancer-causing when used properly.